1. What are OPEP devices and what evidence is emerging that these devices are an option for management of patients following an acute exacerbation of COPD? (0:04)
2. Do all OPEP devices perform the same? (1:01)
View Part 1: Relevance of Acute Exacerbations of COPD, here.
View Part 3: Aerobika* OPEP Device and AECOPD Recovery, here.
Speaker disclosures: Brian Carlin has been on advisory panels for AstraZeneca Pharmaceuticals LP, GlaxoSmithKline, Nonin Medical Inc., Philips Respironics, and Sunovion Pharmaceuticals Inc., and a speaker for Monaghan Medical Corporation, Philips Respironics, and Sunovion Pharmaceuticals Inc.
Filmed at the CHEST Annual Meeting, Toronto, Canada, October 2017, with support from Trudell Medical International.